|
Treatment of Dry AMD and Other Ophthalmic Diseases
Application
Fulvene and fulvalene compounds that inhibit nicotinamide adenine dinucleotide phosphate (NADPH) oxidases for the treatment of ophthalmic diseases and disorders including the dry form of age-related macular degeneration.
Key Benefits
Lead compound candidate identified.
Demonstrated positive effects in in vivo preclinical ocular models...
Published: 1/20/2026
Contributor(s): Jack Arbiser
|